PCI Biotech: Invitation to second quarter and first half 2020 results presentation
August 19, 2020 03:21 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 19 August 2020 - PCI Biotech’s (OSE: PCIB) second quarter and first half 2020 interim report will be released on 26 August 2020 at 07.00 CEST. The interim report and presentation will be...
PCI Biotech: Publication of case report series from the Phase I study in bile duct cancer
August 19, 2020 02:22 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 19 August 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that a case report series from the Phase I study with PCI Biotech's proprietary...
PCI Biotech: Update on the preclinical research collaboration agreement with AstraZeneca
July 13, 2020 13:31 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 13 July 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced a 6 month extension of the evaluation period under its preclinical research...
PCI Biotech: Minutes from Annual General Meeting 2020
May 27, 2020 06:04 ET
|
PCI Biotech Holding ASA
Oslo, 27 May 2020. The Annual General Meeting in PCI Biotech Holding ASA took place today, 27 May 2020. All proposals were resolved by the Annual General Meeting as presented in the notice convening...
PCI Biotech: Disclosure of voting rights for Chairman of the Board
May 26, 2020 07:20 ET
|
PCI Biotech Holding ASA
Oslo, 26 May 2020. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...
PCI Biotech: Notice of Annual General Meeting 2020
May 06, 2020 05:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway 6 May 2020 - The Annual General Meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 27 May 2020 at 10:00am (CEST). Due to...
PCI Biotech: First quarter 2020 results
May 06, 2020 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 6 May 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first quarter 2020 results. Please find enclosed the report and...
PCI Biotech appoints Mr Ludovic Robin as Chief Business Officer
April 30, 2020 03:54 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 30 April 2020 - PCI Biotech announces the appointment of Mr Ludovic Robin, PharmD, MBA, as Chief Business Officer (CBO). Mr Robin will also serve as a member of PCI Biotech’s executive...
PCI Biotech: Invitation to Q1 2020 results presentation
April 28, 2020 07:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 28 April 2020 - PCI Biotech’s Q1 2020 interim report will be released on 6 May, 2020 at 07.00 CEST. The interim report and presentation will be made available on www.newsweb.no and on...
PCI Biotech Holding ASA publishes the Annual Report 2019
April 22, 2020 02:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, April 22, 2020. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2019 and the report is attached. The Annual Report 2019 is also available on the...